UAB Hematology Review 2021
Avatar

Interferon for PV: Types, MOA, Effects in MPN, Pegylation of IFN, PEG vs. HU for High-Risk Disease, IFN Alfa-2 vs. HU, PEG-IFN Alfa-2b

By UAB Hematology Review 2021 FEATURING Pankit Vachhani
By UAB Hematology Review 2021 FEATURING Pankit Vachhani
360 views
March 18, 2021
Comments 0
Login to view comments. Click here to Login

Featured Video

16:51
Incyte

Effects of PV Treatment on White Blood Cell Count and Thrombotic Risk

Feat. C. Harrison

Featured Video

07:44
Incyte

Optimizing the Management of Patients with Polycythemia Vera (PV)

Feat. P. Bose, R. Rampal

Related Videos

24:08

Evaluation, Diagnosis, Prognostication, and Emerging Therapies for M…

Indy Hematology Review

A. Tefferi

1.4K views
24:35

Current Approaches in the Treatment of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

1.3K views
22:21

2024 Updates on Myeloproliferative Neoplasms, PV, and ET

Integrity CE

A. Tefferi

270 views
24:27

Experts Discuss Pros and Cons of Treatment Approaches in PV

BMFcases

T. Bat, A. Tefferi

543 views
23:35

2024 Updates in PV/ET

University of Colorado Division of Hematology

B. McMahon

672 views
08:18

Treatment Strategies for Hematocrit Control in PV

Insights from 2023 ASH Annual Meeting

A. Zhou

908 views
17:05

Diagnosis and Prognosis in PV: Utility of BM Biopsy, Clinical Findin…

BMFcases

T. Bat, A. Tefferi

475 views
27:37

Review of Myeloproliferative Neoplasms

Indy Hematology Review

A. Tefferi

2.7K views
25:44

Myeloid Malignancies: Hot Topics in 2024

Yale Cancer Center

N. Podoltsev

205 views
16:26
Incyte

Effects of a Treatment Option on Hematocrit Control and Spleen Volum…

Feat. C. Harrison
08:49

Experts Address Clinical Questions in PV: Utility of Aspirin, Rusfer…

BMFcases

T. Bat, A. Tefferi

254 views
21:52

ASH 2023 Summary: "MF, ET, and PV - Highlights and Clinical Implicat…

Insights from 2023 ASH Annual Meeting

D. Tremblay

403 views
15:43
Incyte

Importance of Early Management of Patients with Myelofibrosis (MF)

Feat. P. Bose, R. Rampal
10:02

ASH 2023 Summary: "The Best of MPNs - Highlights & Key Takeaways"

Insights from 2023 ASH Annual Meeting

R. Mesa

360 views
05:20

When to Switch From Hydroxyurea to Ruxolitinib in PV

Prithviraj Bose

509 views
08:11

Counseling Patients With Newly Diagnosed PV or ET

Krisstina Gowin

204 views
19:47

CYTO-PV Study: Importance of Hematocrit Control and Early Interventi…

Monia Marchetti

246 views
09:27

MAJIC-PV Trial: Ruxolitinib vs. Best Available Therapy for PV Intole…

ASH 2022 Conference Coverage

M. McMullin

1.1K views
13:38

Top 5 Impactful MPN Abstracts From Summer Conferences

Insights from 2024 EHA Annual Meeting

P. Bose

157 views
16:25

Diagnosis and Goals of Therapy in PV

Northwestern Medicine Oncology and Hematology

B. Stein

819 views
AUTOPLAY